Stockscreener 앱 받기
8.34
5.06%
0.43
전일 마감가:
$7.91
열려 있는:
$7.8
하루 거래량:
352.06K
Relative Volume:
0.32
시가총액:
$639.09M
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-2.5183
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
+13.06%
1개월 성능:
+1.59%
6개월 성능:
-30.23%
1년 성능:
-46.32%
1일 변동 폭
$7.7557
$8.40
1주일 범위
$6.96
$8.40
52주 변동 폭
$5.1501
$16.81
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
8.35 | 639.09M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.88 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.59 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
602.73 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.37 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Immunome: Transformed Pipeline Offers Multiple Catalysts (NASDAQ:IMNM) - Seeking Alpha
JPMorgan Chase & Co. Acquires 624,045 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
How To Trade (IMNM) - news.stocktradersdaily.com
Wellington Management Group LLP Raises Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Vanguard Group Inc. Sells 128,130 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome Announces Management Changes - marketscreener.com
KLP Kapitalforvaltning AS Invests $75,000 in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Corebridge Financial Inc. Sells 1,929 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Commonwealth Equity Services LLC Buys Shares of 19,017 Immunome, Inc. (NASDAQ:IMNM) - Defense World
Raymond James Financial Inc. Acquires Shares of 25,817 Immunome, Inc. (NASDAQ:IMNM) - Defense World
Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance
Brokerages Set Immunome, Inc. (NASDAQ:IMNM) PT at $25.14 - Defense World
Immunome stock hits 52-week low at $5.5 amid market challenges - Investing.com
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Immunome's Latest Cancer Therapy Progress: Key Investor Presentation Coming to Needham Conference - Stock Titan
Lake Street Capital Begins Coverage on Immunome (NASDAQ:IMNM) - Defense World
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
Teacher Retirement System of Texas Purchases New Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Clay Siegall Bought 20% More Shares In Immunome - simplywall.st
Corient Private Wealth LLC Sells 12,149 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome stock hits 52-week low at $6.94 amid market challenges - Investing.com Australia
Immunome stock hits 52-week low at $6.94 amid market challenges By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Stock Price Up 4.4% After Insider Buying Activity - Defense World
Immunome (IMNM) Stock Climbs as Executives Increase Holdings - GuruFocus
Immunome director Jean Jacques Bienaime acquires $60,684 in stock - Investing.com
Immunome director Jean Jacques Bienaime acquires $60,684 in stock By Investing.com - Investing.com South Africa
Immunome CEO Clay Siegall buys $999k in stock By Investing.com - Investing.com Canada
Immunome CEO Clay Siegall buys $999k in stock - Investing.com India
Immunome stock rises after insider purchase (IMNM:NASDAQ) - Seeking Alpha
Immunome stock rises after insider purchase - MSN
Immunome director Jean Jacques Bienaime purchases $57,470 in stock By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Increases Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome CTO Philip Tsai purchases $103,566 in stock By Investing.com - Investing.com Canada
Immunome director Jean Jacques Bienaime purchases $57,470 in stock - Investing.com
Immunome CTO Philip Tsai purchases $103,566 in stock - Investing.com
Bank of New York Mellon Corp Has $1.31 Million Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Wedbush Has Positive Estimate for Immunome Q1 Earnings - Defense World
Immunome (NASDAQ:IMNM) Receives Outperform Rating from Wedbush - MarketBeat
Immunome’s (IMNM) “Outperform” Rating Reiterated at Wedbush - Defense World
Guggenheim Has Lowered Expectations for Immunome (NASDAQ:IMNM) Stock Price - Defense World
Stephens Reiterates Overweight Rating for Immunome (NASDAQ:IMNM) - Defense World
Trading (IMNM) With Integrated Risk Controls - news.stocktradersdaily.com
Immunome Full Year 2024 Earnings: Misses Expectations - Yahoo
Immunome’s 2024 Financial Results and Pipeline Progress - TipRanks
Immunome stock target cut to $25 by Guggenheim - Investing.com Australia
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이뮤놈 주식 (IMNM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
| SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
| BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
| Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
| SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
| SIEGALL CLAY B | President and CEO |
Nov 21 '24 |
Buy |
9.54 |
66,057 |
630,263 |
485,693 |
| SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
| Lechleider Robert | Chief Medical Officer |
Nov 21 '24 |
Buy |
9.48 |
15,805 |
149,800 |
15,805 |
| Tsai Philip | Chief Technology Officer |
Nov 21 '24 |
Buy |
9.43 |
21,000 |
198,030 |
21,000 |
| Rosett Max | Chief Financial Officer |
Sep 19 '24 |
Option Exercise |
1.05 |
42,000 |
44,100 |
61,856 |
0.77%
0.11%
자본화:
|
볼륨(24시간):